Ellen de Brabander - 03 Mar 2025 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)

Role
Executive Vice President of Innovation and Regulatory Affairs
Signature
/s/ Amy C. Seidel, as Attorney-in-Fact for Ellen de Brabander
Issuer symbol
ELAN
Transactions as of
03 Mar 2025
Net transactions value
$0
Form type
4
Filing time
05 Mar 2025, 18:50:32 UTC
Previous filing
04 Mar 2025
Next filing
13 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELAN Common Stock Award $0 +50,575 +30% $0.000000 221,740 03 Mar 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELAN Employee Stock Option (right to buy) Award $0 +106,123 $0.000000 106,123 03 Mar 2025 Common Stock 106,123 $11.31 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of restricted stock units vesting as follows: one-third vesting on March 3, 2026, one-third vesting on March 3, 2027, and the remaining vesting on March 3, 2028.
F2 Grant of stock options vesting as follows: one-third vesting on March 3, 2026, one-third vesting on March 3, 2027, and the remaining vesting on March 3, 2028.

Remarks:

Executive Vice President of Innovation and Regulatory Affairs